CANC Holdings Information

CANC is an equity ETF with a total of 58 individual holdings. The top holdings are Revolution Medicines stock at 6.06%, Eli Lilly and Company at 5.28%, Cogent Biosciences at 5.08%, Roche Holding AG at 4.50%, and Novartis AG at 4.07%.

Total Holdings

Top 10 Percentage

41.93%

Asset Class

Equity

ETF Category

Health

Assets

195.63M

PE Ratio

19.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	6.06%	63,247
2	LLY	Eli Lilly and Company	5.28%	8,776
3	COGT	Cogent Biosciences, Inc.	5.08%	248,859
4	RHHBY	Roche Holding AG	4.50%	164,351
5	SWX: NOVN	Novartis AG	4.07%	51,288
6	ABBV	AbbVie Inc.	3.74%	28,678
7	MRK	Merck & Co., Inc.	3.59%	54,232
8	BMY	Bristol-Myers Squibb Company	3.45%	110,383
9	JNJ	Johnson & Johnson	3.35%	25,430
10	EXEL	Exelixis, Inc.	2.80%	99,184
11	CGON	CG Oncology, Inc.	2.74%	75,809
12	LON: AZN	AstraZeneca PLC	2.73%	31,809
13	IMNM	Immunome, Inc.	2.71%	242,305
14	LEGN	Legend Biotech Corporation	2.69%	225,381
15	GMAB	Genmab A/S	2.65%	179,232
16	AMGN	Amgen Inc.	2.60%	13,801
17	IDYA	IDEAYA Biosciences, Inc.	2.56%	139,070
18	BBIO	BridgeBio Pharma, Inc.	2.51%	59,543
19	ONC	BeOne Medicines AG	2.27%	13,662
20	HALO	Halozyme Therapeutics, Inc.	2.03%	49,529
21	CELC	Celcuity Inc.	1.88%	41,880
22	ELVN	Enliven Therapeutics, Inc.	1.86%	69,524
23	ERAS	Erasca, Inc.	1.83%	186,772
24	RLAY	Relay Therapeutics, Inc.	1.75%	180,973
25	ZLAB	Zai Lab Limited	1.58%	157,648

Showing 25 of 58 holdings

Subscribe to see the full list

Activate Now

As of Jul 23, 2026